Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03206788 · ClinicalTrials.gov registry record · Phase 2
Losartan and Inflammation in Cystic Fibrosis
A Phase 2 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT03206788 is a Phase 2 study that was terminated before completion, run by University of Miami. The registered enrollment target is 7 participants.
The verdict
NCT03206788, a Phase 2 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of the study is to examine if a specific drug called losartan (Cozaar ®), generally used to treat high blood pressure and to protect kidneys from damage in patients suffering from Diabetes Mellitus, will have any effect on the nasal inflammation in patients with cystic fibrosis (CF). The study will be performed at the Pulmonary Division at the University of Miami, Cincinnati Children's Medical Hospital Center, University of Kansas Medical Center and University of Alabama-Birmingham.
Interventions
- DRUG placebo
- DRUG Losartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-11-11 |
| Est. Completion | 2019-12-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03206788
The ClinicalTrials.gov registry entry for NCT03206788 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT03206788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03206788 about?
NCT03206788 is a clinical study titled "Losartan and Inflammation in Cystic Fibrosis". The purpose of the study is to examine if a specific drug called losartan (Cozaar ®), generally used to treat high blood pressure and to protect kidneys from damage in patients suffering from Diabetes Mellitus, will have any effect on the nasal inflammation in patients with cystic fibrosis (CF). The...
What is the current status of trial NCT03206788?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2017-11-11. Estimated completion is 2019-12-30.
What interventions are being tested in trial NCT03206788?
The interventions under investigation include: placebo (DRUG), Losartan (DRUG).
Who is sponsoring clinical trial NCT03206788?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.